Miranda Carter and Emily Lawson to join SCCL Board

23 October 2019

NHS Supply Chain is delighted to announce that Miranda Carter and Emily Lawson have been appointed as Directors to the Board of Supply Chain Coordination Limited (SCCL). They will represent the interests of NHS England and NHS Improvement and bring a wealth of experience and expertise to NHS Supply Chain.

Miranda Carter is currently Director of Provider Transformation at NHS England and NHS Improvement. Miranda joined Monitor in 2004 where she was responsible for the assessment of NHS foundation trust applications and reviewing NHS mergers & acquisitions. More recently she has taken responsibility for the provider transformation and provider policy teams within NHS England and Improvement focusing on the development of the provider sector within systems to support the delivery of the NHS long term plan commitments.

A qualified chartered accountant, Miranda started her career at Deloitte working in the UK and Hong Kong. In 1997 she joined PricewaterhouseCoopers and spent four years in the Transaction Services Department in London focusing on due diligence assignments. Her portfolio of financial experience is wide-ranging and includes mergers and acquisitions, due diligence and initial public offerings (IPOs).

Emily Lawson joined NHS England and NHS Improvement as National Director for Transformation and Corporate Operations in November 2017. She is responsible for a range of enabling corporate functions which support the effectiveness and efficiency of NHS England and NHS Improvement, with a focus on leading the transformation agenda for the organisation.

A Molecular Geneticist by background, Emily has led a number of large-scale organisational change programmes. Before joining NHS England and NHS Improvement, Emily was Chief People Officer at Kingfisher plc where she was part of the international leadership team. Prior to that, she was Group HRD at Morrisons and spent 15 years at McKinsey, where she worked across a variety of sectors leading transformation. She is also Deputy Chair of the 30% club, which aims to increase representation of women on UK plc boards, and to research and support greater diversity in the UK and global institutions.

I am pleased to welcome both Miranda and Emily to the Board. It is further evidence of collaborative working and transparency across the NHS. With their extensive experience in transformation and development I am confident they will help drive the success of NHS Supply Chain.Jim Spittle, Chair
SCCL
I am thrilled to be joining the board of Supply Chain Coordination Limited. My previous experience and current role at NHS England and NHS Improvement will help to boost ideas and increase the buying power of the NHS to ensure more money is available for our frontline services.Miranda Carter, Director of Provider Transformation
NHS England and NHS Improvement
This is an excellent opportunity to continue our collaboration to drive improvements for the NHS and the public. I look forward to working together to consolidate our procurement function which will help trusts save money to reinvest into patient care.Emily Lawson, National Director for Transformation and Corporate Operations
NHS England and NHS Improvement

-ends-

Media Enquiries:

Jennie Brice

Corporate Communications Manager

Joanna Morrison

Head of Public Affairs and PR

 
Notes to Editors:

About NHS Supply Chain

All information in this press release is correct at the time of going to press.

NHS Supply Chain supports the National Health Service (NHS) and other healthcare organisations in England and Wales by providing end to end supply chain solutions.

NHS Supply Chain is managed by Supply Chain Co-ordination Ltd, a limited company wholly owned by the Department of Health and Social Care. The management function went live on 1 April 2018 and manages the performance of the 11 category tower service providers along with the logistics and IT providers.

NHS Supply Chain manages the sourcing, delivery and supply of healthcare products and food for NHS trusts and healthcare organisations. It provides a single point of access to over 316,000 nationally available, transactable lines ranging from bandages to sutures, from gloves to implants, and surgical equipment. In addition, it can help plan investments in medical capital equipment such as MRI scanners, linear accelerators and patient monitors.

Its management of the procurement process negates an NHS organisation’s need to tender through the Official Journal of the European Union (OJEU). Costs can also be reduced through its one-route solution that consolidates all products onto one invoice and delivery.

To ensure that its products are fit for today’s healthcare market, NHS Supply Chain works with suppliers of all sizes to ensure its range embraces high quality and innovative products; and engages with clinicians, the Department of Health and Social Care and academic institutions to make sure that it is aware of the current requirements and latest developments in clinical practice.

NHS Supply Chain’s product areas (Category Towers) include:

  • Ward Based Consumables
  • Sterile Intervention Equipment and Associated Consumables
  • Infection Control and Wound Care
  • Orthopaedics, Trauma and Spine and Ophthalmology
  • Rehabilitation, Disabled Services, Women’s Health and Associated Consumables
  • Cardiovascular, Radiology, Endoscopy, Audiology and Pain Management
  • Large Diagnostic Capital Equipment including Mobile and Services
  • Diagnostic, Pathology and Therapy Technologies and Services
  • Office Solutions
  • Food
  • Hotel Services

www.supplychain.nhs.uk